Pancreatic Cancer Research

ResearcherTokyo Medical UniversityNo recent work listed

Shigeyuki Kawachi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1623-4181; OpenAlex author ID A5101703285. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper

Papers 10

  1. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer. Last author DOI 10.18632/oncotarget.28235↗
  2. Prognostic Significance of Plasma Fibrinogen/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.21873/anticanres.14727↗
  3. Overexpression of hydroxyproline via EGLN/HIF1A is associated with distant metastasis in pancreatic cancer. Last author PMID 32905516↗
  4. Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializi… Co-author DOI 10.1245/s10434-018-07131-8↗
  5. Elevated Polyamines in Saliva of Pancreatic Cancer. Co-author DOI 10.3390/cancers10020043↗
  6. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Co-author DOI 10.3390/ijms18040767↗
  7. Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. Co-author DOI 10.2302/kjm.2014-0014-cr↗
  8. [The Efficacy of Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer]. Last author PMID 26805072↗
  9. Computer assisted surgery, preoperative planning and navigation for pancreatic cancer. Co-author DOI 10.1002/jhbp.84↗
  10. Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells. Co-author DOI 10.1111/cas.12059↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Naokazu Chiba · 5 shared papers, 2014–2022 · strength 0.48
  2. Toru Sano · 4 shared papers, 2015–2022 · strength 0.44
  3. Koichi Tomita · 4 shared papers, 2015–2022 · strength 0.44
  4. Makoto Sunamura · 3 shared papers, 2017–2020 · strength 0.21
  5. Yuichi Nagakawa · 3 shared papers, 2017–2019 · strength 0.19
  6. Yuta Abe · 3 shared papers, 2014–2017 · strength 0.14
  7. Reina Tanaka · 2 shared papers, 2017–2018 · strength 0.11
  8. Atsushi Sofuni · 2 shared papers, 2017–2018 · strength 0.11
  9. Ryosuke Tonozuka · 2 shared papers, 2017–2018 · strength 0.11
  10. Takao Itoi · 2 shared papers, 2017–2018 · strength 0.11
  11. Yuko Kitagawa · 3 shared papers, 2013–2015 · strength 0.11
  12. Minoru Kitago · 2 shared papers, 2014–2015 · strength 0.08
  13. Yuichi Hosokawa · 1 shared paper, 2019 · strength 0.07
  14. Yoshiaki Murakami · 1 shared paper, 2019 · strength 0.07
  15. Sohei Satoi · 1 shared paper, 2019 · strength 0.07
  16. Shuji Isaji · 1 shared paper, 2019 · strength 0.07
  17. Tetsuo Ohta · 1 shared paper, 2019 · strength 0.07
  18. Masayuki Sho · 1 shared paper, 2019 · strength 0.07
  19. Hiroki Yamaue · 1 shared paper, 2019 · strength 0.07
  20. Shuji Suzuki · 1 shared paper, 2019 · strength 0.07
  21. Akihiko Tsuchida · 1 shared paper, 2019 · strength 0.07
  22. Michiaki Unno · 1 shared paper, 2019 · strength 0.07
  23. Tsutomu Fujii · 1 shared paper, 2019 · strength 0.07
  24. Itaru Endo · 1 shared paper, 2019 · strength 0.07
  25. Koichi Aiura · 2 shared papers, 2013–2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.